158 related articles for article (PubMed ID: 30165645)
1. A Streptococcus suis Live Vaccine Suppresses Streptococcal Toxic Shock-Like Syndrome and Provides Sequence Type-Independent Protection.
Li Z; Chang P; Xu J; Tan C; Wang X; Bei W; Li J
J Infect Dis; 2019 Jan; 219(3):448-458. PubMed ID: 30165645
[TBL] [Abstract][Full Text] [Related]
2. Construction, characterization and evaluation of the protective efficacy of the Streptococcus suis double mutant strain ΔSsPep/ΔSsPspC as a live vaccine candidate in mice.
Hu J; You W; Wang B; Hu X; Tan C; Liu J; Chen H; Bei W
Microbiol Res; 2015 Jan; 170():87-94. PubMed ID: 25220429
[TBL] [Abstract][Full Text] [Related]
3. Streptococcus suis vaccines: candidate antigens and progress.
Segura M
Expert Rev Vaccines; 2015; 14(12):1587-608. PubMed ID: 26468755
[TBL] [Abstract][Full Text] [Related]
4. Deletion of ssnA Attenuates the Pathogenicity of Streptococcus suis and Confers Protection against Serovar 2 Strain Challenge.
Li M; Cai RJ; Li CL; Song S; Li Y; Jiang ZY; Yang DX
PLoS One; 2017; 12(1):e0169791. PubMed ID: 28081204
[TBL] [Abstract][Full Text] [Related]
5. Live Streptococcus suis type 5 strain XS045 provides cross-protection against infection by strains of types 2 and 9.
Jiang X; Yang Y; Zhu L; Gu Y; Shen H; Shan Y; Li X; Wu J; Fang W
Vaccine; 2016 Dec; 34(51):6529-6538. PubMed ID: 27349838
[TBL] [Abstract][Full Text] [Related]
6. Live attenuated Salmonella enterica serovar Choleraesuis vaccine vector displaying regulated delayed attenuation and regulated delayed antigen synthesis to confer protection against Streptococcus suis in mice.
Ji Z; Shang J; Li Y; Wang S; Shi H
Vaccine; 2015 Sep; 33(38):4858-67. PubMed ID: 26238722
[TBL] [Abstract][Full Text] [Related]
7. Protection against Streptococcus suis Serotype 2 Infection Using a Capsular Polysaccharide Glycoconjugate Vaccine.
Goyette-Desjardins G; Calzas C; Shiao TC; Neubauer A; Kempker J; Roy R; Gottschalk M; Segura M
Infect Immun; 2016 Jul; 84(7):2059-2075. PubMed ID: 27113360
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the protective efficacy of four novel identified membrane associated proteins of Streptococcus suis serotype 2.
Zhou Y; Wang Y; Deng L; Zheng C; Yuan F; Chen H; Bei W; Li J
Vaccine; 2015 May; 33(19):2254-2260. PubMed ID: 25820064
[TBL] [Abstract][Full Text] [Related]
9. Effect of the glycosyltransferases on the capsular polysaccharide synthesis of Streptococcus suis serotype 2.
Zhang Y; Ding D; Liu M; Yang X; Zong B; Wang X; Chen H; Bei W; Tan C
Microbiol Res; 2016 Apr; 185():45-54. PubMed ID: 26946377
[TBL] [Abstract][Full Text] [Related]
10. Comparative Study of Immunogenic Properties of Purified Capsular Polysaccharides from
Goyette-Desjardins G; Auger JP; Dolbec D; Vinogradov E; Okura M; Takamatsu D; Van Calsteren MR; Gottschalk M; Segura M
Infect Immun; 2020 Sep; 88(10):. PubMed ID: 32747605
[No Abstract] [Full Text] [Related]
11. The genetically modified suilysin, rSLY(P353L), provides a candidate vaccine that suppresses proinflammatory response and reduces fatality following infection with Streptococcus suis.
Du H; Huang W; Xie H; Ye C; Jing H; Ren Z; Xu J
Vaccine; 2013 Aug; 31(38):4209-15. PubMed ID: 23856333
[TBL] [Abstract][Full Text] [Related]
12. Immunogenicity and cross-protective efficacy of double-mutant Streptococcus suis ΔSspepO/ΔSspspC serotypes 2 and 7.
Hu J; Xu J; Liu F; Tan C; Yuan F; Chen H; Bei W
Vaccine; 2019 Apr; 37(16):2194-2199. PubMed ID: 30902483
[TBL] [Abstract][Full Text] [Related]
13. Assessment of protective efficacy of live and killed vaccines based on a non-encapsulated mutant of Streptococcus suis serotype 2.
Wisselink HJ; Stockhofe-Zurwieden N; Hilgers LA; Smith HE
Vet Microbiol; 2002 Jan; 84(1-2):155-68. PubMed ID: 11731168
[TBL] [Abstract][Full Text] [Related]
14. The VraSR regulatory system contributes to virulence in Streptococcus suis via resistance to innate immune defenses.
Chang P; Li W; Shi G; Li H; Yang X; Xia Z; Ren Y; Li Z; Chen H; Bei W
Virulence; 2018 Dec; 9(1):771-782. PubMed ID: 29471718
[TBL] [Abstract][Full Text] [Related]
15. Fisher scientific award lecture - the capsular polysaccharides of Group B Streptococcus and Streptococcus suis differently modulate bacterial interactions with dendritic cells.
Segura M
Can J Microbiol; 2012 Mar; 58(3):249-60. PubMed ID: 22356626
[TBL] [Abstract][Full Text] [Related]
16. Live-attenuated Salmonella enterica serotype Choleraesuis vaccine with regulated delayed fur mutation confer protection against Streptococcus suis in mice.
Li YA; Chen Y; Du YZ; Guo W; Chu D; Fan J; Wang X; Bellefleur M; Wang S; Shi H
BMC Vet Res; 2020 May; 16(1):129. PubMed ID: 32381017
[TBL] [Abstract][Full Text] [Related]
17. Genome-wide analysis of an avirulent strain that induces protective immunity against challenge with virulent Streptococcus suis serotype 2.
Wang J; Feng Y; Wang C; Zheng F; Hassan B; Zhi L; Li W; Yao Y; He E; Jiang S; Tang J
BMC Microbiol; 2017 Mar; 17(1):67. PubMed ID: 28292261
[TBL] [Abstract][Full Text] [Related]
18. Screening for phagocytosis resistance-related genes via a transposon mutant library of
Pei X; Liu M; Zhou H; Fan H
Virulence; 2020 Dec; 11(1):825-838. PubMed ID: 32614642
[TBL] [Abstract][Full Text] [Related]
19. Role of suilysin in pathogenesis of Streptococcus suis capsular serotype 2.
Lun S; Perez-Casal J; Connor W; Willson PJ
Microb Pathog; 2003 Jan; 34(1):27-37. PubMed ID: 12620382
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the immune response and evaluation of the protective capacity of rSsnA against Streptococcus suis infection in pigs.
Gómez-Gascón L; Cardoso-Toset F; Tarradas C; Gómez-Laguna J; Maldonado A; Nielsen J; Olaya-Abril A; Rodríguez-Ortega MJ; Luque I
Comp Immunol Microbiol Infect Dis; 2016 Aug; 47():52-9. PubMed ID: 27477507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
